• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOVENTUS LLC. DUROLANE 60 MG/3ML SYR (3=1); ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOVENTUS LLC. DUROLANE 60 MG/3ML SYR (3=1); ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Patient Problems Hypersensitivity/Allergic reaction (1907); Pain (1994); Swelling/ Edema (4577)
Event Type  Injury  
Event Description
Pt report that he had gotten a durolane injection from the mdo office and needs to replace it, but pt had reaction after getting the injection.Pt stated that his knee locked up and the whole knee started to swell which caused a lot of pain.Pt had to go to the er and get durolane sucked removed.Pt has not received first dose from arxwp.Inject 1 syringe intra-articularly into the affected knee.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DUROLANE 60 MG/3ML SYR (3=1)
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
BIOVENTUS LLC.
MDR Report Key17842660
MDR Text Key324701190
Report NumberMW5146285
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 09/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received09/28/2023
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexMale
-
-